Australian health technology company EncapSolutions has officially launched its first range of SkinSync Natural Health Patches at Newtopia, a leading wellness event in Denver, Colorado.
The debut marks the company’s entry into the US market and the unveiling of a platform it believes could transform how therapeutic ingredients are delivered through the skin.
The new line of patches is built on EncapSolutions’ proprietary SkinSync technology, which uses biodegradable polymeric nanofibres that dissolve on contact with moist skin. The system enables the precise and controlled delivery of natural ingredients, including CBD, while also providing an environmentally responsible alternative to traditional transdermal products.
EncapSolutions CEO Chris Barbé said the launch was the culmination of three years of focused research and development. “Three years might sound like a long time, but in high-tech product development it’s lightning speed,” he said. “We built this platform from the ground up, without compromise, to ensure both trust and scalability. For us this step is a demonstration of our platform technology—one that can, and has been, tested with more traditional APIs such as lidocaine and fentanyl. We remain committed to biotech and the development of pharmaceutical-grade transdermal products.”
EncapSolutions has secured strong industry collaborations to support its entry into the US, establishing a supply chain and commercialisation pathway geared for rapid market penetration. The company states that its SkinSync technology provides a defensible and scalable platform, positioning it to expand beyond natural health applications into regulated pharmaceuticals, including future opportunities in pain management and other therapeutic areas.